Opportunity Information: Apply for PAR 16 189
Apply for PAR 16 189
- The HHS-NIH11 in the education, health sector is offering a public funding opportunity titled "Paul Calabresi Career Development Award for Clinical Oncology (K12)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398,.
- This funding opportunity was created on Apr 14, 2016 and posted on Apr 14, 2016.
- Applicants must submit their applications by Jun 15, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Paul Calabresi Career Development Award for Clinical Oncology (K12) is a National Institutes of Health (NIH) funding opportunity that supports institutional career development programs focused on building the next generation of clinical trials researchers in oncology and related clinical therapeutic research areas. Rather than funding a single individual, this K12 mechanism is designed to help an eligible organization create and run a structured training and mentored career development program that recruits, supports, and develops multiple early-career scholars over time. The overall intent is to strengthen the national pipeline of investigators who can design, implement, and evaluate clinical therapeutic research protocols in real-world clinical trial environments.
At its core, the program targets the training of professionals who will lead or substantially contribute to clinical trials across the spectrum of trial phases, including pilot and Phase I studies (often emphasizing safety, dosing, and feasibility), Phase II trials (typically focused on preliminary efficacy and further safety), and Phase III trials (larger, comparative studies that can change standards of care). The emphasis is on clinical therapeutic research, meaning the award is geared toward preparing investigators to test interventions and treatments in patients through well-designed clinical research protocols, not just observational studies. The aim is practical and workforce-oriented: increasing the number of highly trained clinical trials researchers who can move promising therapies through rigorous testing and ultimately improve patient outcomes.
The FOA specifically highlights a broad range of potential scholar backgrounds, reflecting how multidisciplinary clinical trials work has become. It is intended to support clinicians such as M.D.s and D.O.s, Pharm.D.s involved in therapeutic development and evaluation, and nurses who hold Ph.D.s or equivalent research doctorates, alongside non-clinician postdoctoral researchers whose work is directly relevant to clinical therapeutic trials. In other words, the program is not limited to physicians; it recognizes that modern clinical trials require expertise spanning clinical care, pharmacology, nursing science, biostatistics, trial operations, ethics, regulatory compliance, and translational research, and it encourages institutional programs that can nurture talent across those domains.
Administrative details in the source indicate this is a discretionary grant opportunity offered by HHS/NIH (listed as HHS-NIH11) under the Funding Opportunity Number PAR-16-189. The activity sits in the education and health category and is associated with CFDA numbers 93.398 (and also lists 93.398 again in the data provided). The opportunity was posted on April 14, 2016, with an original and current closing date shown as June 15, 2018. While the listing does not provide an award ceiling, expected award counts, or other budget figures in the fields shown, the key takeaway is that institutions apply to establish or maintain a formal K12 program that provides mentored career development support to multiple trainees.
Eligibility is intentionally broad and includes many types of organizations that can plausibly host a high-quality clinical trials training environment. Eligible applicants include public and private institutions of higher education; state, county, city, township, and special district governments; independent school districts; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding institutions of higher education where specified); for-profit organizations other than small businesses; and small businesses, with a note that “Others” may be eligible depending on the additional eligibility text in the full announcement. This breadth suggests NIH’s interest in enabling a variety of research ecosystems to build capacity, so long as they can credibly provide the mentoring, clinical trial infrastructure, and research environment needed for scholars to develop into independent clinical trials investigators.
In practical terms, a competitive application under this FOA would be expected to describe a coherent institutional program for career development in clinical trials research: how scholars will be selected, what structured training they will receive (for example, trial design, biostatistics, regulatory requirements, ethics, data safety monitoring, recruitment and retention, and protocol development), how mentoring teams will be organized, and how the institution will ensure scholars gain hands-on experience in designing and conducting clinical therapeutic trials. The spirit of the program is to turn promising early-career researchers into investigators who can not only participate in trials, but also originate strong clinical questions, build feasible and ethical protocols, manage trial conduct, analyze outcomes, and ultimately compete successfully for independent research funding in clinical oncology and therapeutic research.
Frequently Asked Questions (FAQs)
What is the Paul Calabresi Career Development Award for Clinical Oncology (K12)?
The Paul Calabresi Career Development Award for Clinical Oncology (K12) is an NIH funding opportunity that supports institutional career development programs designed to train and mentor the next generation of clinical trials researchers in oncology and related clinical therapeutic research areas.
Is this grant awarded to an individual or to an institution?
This K12 mechanism is awarded to an eligible organization (an institution), not a single individual. The institution uses the award to create and run a structured training and mentored career development program that supports multiple early-career scholars over time.
What is the main purpose of this K12 program?
The overall intent is to strengthen the national pipeline of investigators who can design, implement, and evaluate clinical therapeutic research protocols in real-world clinical trial environments, ultimately increasing the number of well-trained clinical trials researchers and improving patient outcomes through rigorous testing of therapies.
What types of research does this program emphasize?
The program emphasizes clinical therapeutic research, meaning research focused on testing interventions and treatments in patients through well-designed clinical research protocols. It is aimed at preparing investigators to lead or substantially contribute to clinical trials rather than focusing primarily on observational studies.
What clinical trial phases are covered under the training focus?
The program targets training across the spectrum of clinical trial phases, including pilot and Phase I studies (often focused on safety, dosing, and feasibility), Phase II trials (typically focused on preliminary efficacy and additional safety), and Phase III trials (larger comparative studies that may change standards of care).
What kinds of scholars or trainee backgrounds does the FOA encourage?
The FOA highlights multidisciplinary scholar backgrounds, including clinicians such as M.D.s and D.O.s, Pharm.D.s involved in therapeutic development and evaluation, nurses with Ph.D.s or equivalent research doctorates, and non-clinician postdoctoral researchers whose work is directly relevant to clinical therapeutic trials.
Is this opportunity limited to physicians?
No. The program is explicitly described as not limited to physicians and reflects the multidisciplinary nature of modern clinical trials. It encourages programs that can develop talent spanning domains such as clinical care, pharmacology, nursing science, biostatistics, trial operations, ethics, regulatory compliance, and translational research.
What does the award support institutions in doing?
The award supports institutions in establishing or maintaining a formal K12 program that provides structured training and mentored career development for multiple scholars. The program is intended to build scholars into investigators who can participate in trials and also develop strong clinical questions, create ethical and feasible protocols, manage trial conduct, analyze outcomes, and compete for independent research funding.
What might a competitive institutional program application be expected to describe?
Based on the description provided, a competitive application would be expected to outline a coherent institutional program, including how scholars will be selected, what structured training they will receive, how mentoring teams will be organized, and how scholars will gain hands-on experience designing and conducting clinical therapeutic trials.
What are examples of training topics the program may include?
Examples mentioned include clinical trial design, biostatistics, regulatory requirements, research ethics, data safety monitoring, recruitment and retention, and protocol development, along with practical experience in conducting clinical therapeutic trials.
Who is the sponsoring agency for this funding opportunity?
The sponsoring agency is the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH). The listing references HHS/NIH and identifies the agency as HHS-NIH11.
What is the Funding Opportunity Number (FOA number) for this opportunity?
The Funding Opportunity Number listed is PAR-16-189.
What category does this opportunity fall under?
The opportunity is listed under the education and health category.
What CFDA number is associated with this opportunity?
The listing associates the opportunity with CFDA number 93.398 (and it appears twice in the provided data).
When was this opportunity posted?
The opportunity was posted on April 14, 2016.
What is the closing date shown for this opportunity?
The listing shows an original and current closing date of June 15, 2018.
Does the listing provide award ceiling, expected award counts, or budget figures?
No. The fields shown in the provided listing do not include an award ceiling, expected award counts, or other budget figures. The key point provided is that institutions apply to establish or maintain a formal K12 program supporting multiple trainees.
What types of organizations are eligible to apply?
Eligibility is broad. Eligible applicants include public and private institutions of higher education; state, county, city, township, and special district governments; independent school districts; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding institutions of higher education where specified); for-profit organizations other than small businesses; and small businesses. The listing also notes that "Others" may be eligible depending on additional eligibility language in the full announcement.
Why does the FOA allow such broad organizational eligibility?
The description indicates NIH interest in enabling a variety of research ecosystems to build capacity, as long as the applying organization can credibly provide the mentoring, clinical trial infrastructure, and research environment needed for scholars to develop into independent clinical trials investigators.
What outcomes is the K12 program trying to achieve for scholars?
The program aims to develop investigators who can lead or substantially contribute to clinical trials, move promising therapies through rigorous testing, and ultimately compete successfully for independent research funding in clinical oncology and related therapeutic research.
Browse more opportunities from the same category: Education, Health
Next opportunity: FY 2016 Pan Africa Youth Leadership Program
Previous opportunity: Mechanisms, Models, Measurement, and Management in Pain Research (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 189
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 189) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tools for Cell Line Identification (R43/R44) Apply for PA 16 186 Funding Number: PA 16 186 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Laboratory and Diagnostic Tools to Advance Microbiome-Brain Research (R43/R44) Apply for RFA DA 17 017 Funding Number: RFA DA 17 017 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $150,000 |
| Laboratory and Diagnostic Tools to Advance Microbiome-Brain Research (R41) Apply for RFA DA 17 016 Funding Number: RFA DA 17 016 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $150,000 |
| Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01) Apply for PAR 16 202 Funding Number: PAR 16 202 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21) Apply for PAR 16 201 Funding Number: PAR 16 201 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (R25) Apply for RFA DA 17 007 Funding Number: RFA DA 17 007 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $250,000 |
| NLM Career Development Award in Biomedical Informatics and Data Science (K01) Apply for PAR 16 204 Funding Number: PAR 16 204 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21) Apply for PAR 16 213 Funding Number: PAR 16 213 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01) Apply for PAR 16 212 Funding Number: PAR 16 212 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research (R43/R44) Apply for RFA DA 17 009 Funding Number: RFA DA 17 009 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $150,000 |
| Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research (R41/R42) Apply for RFA DA 17 008 Funding Number: RFA DA 17 008 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $150,000 |
| Research Answers to NCIs Pediatric Provocative Questions (R21) Apply for PAR 16 217 Funding Number: PAR 16 217 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Research Answers to NCIs Pediatric Provocative Questions (R01) Apply for PAR 16 218 Funding Number: PAR 16 218 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Health Services Research on Minority Health and Health Disparities (R21) Apply for PAR 16 222 Funding Number: PAR 16 222 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Health Services Research on Minority Health and Health Disparities (R01) Apply for PAR 16 221 Funding Number: PAR 16 221 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| The Role of Mobile Genetic Elements in Cancer (R21) Apply for PAR 16 226 Funding Number: PAR 16 226 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25) Apply for PAR 16 224 Funding Number: PAR 16 224 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $350,000 |
| The Role of Mobile Genetic Elements in Cancer (R01) Apply for PAR 16 227 Funding Number: PAR 16 227 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Metabolic Reprogramming to Improve Immunotherapy (R21) Apply for PAR 16 229 Funding Number: PAR 16 229 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Non-healing Ulcerative Wounds in Aging (R01) Apply for PA 16 230 Funding Number: PA 16 230 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 189", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
